Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis : 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

• LEONARDI CL

収録刊行物

• Lancet

  Lancet 371 1665-1674, 2008

詳細情報

• CRID: 1572824500829824640
• NII論文ID: 10026432970
• データソース種別:
  • CiNii Articles